期刊文献+

脑钠素与充血性心力衰竭的研究进展

暂未订购
导出
摘要 心脏是维持全身血液循环的动力器官,也是内分泌器官,其分泌多种激素参与人体水电解质平衡及血管张力的调节。脑钠素(BNP)是主要由心室分泌的肽类激素,具有扩张血管、增加排钠、对抗肾上腺素、肾素-血管紧张素等作用。与充血性心力衰竭的发展、预后密切相关。
作者 周翔 李永华
出处 《临床军医杂志》 CAS 2005年第6期761-762,共2页 Clinical Journal of Medical Officers
  • 相关文献

参考文献11

  • 1Sudoh T,Kangawa,minamino N,et al.A-natiuretic peptide in porcine brain[J].Nature,1988,322:78-81.
  • 2Nakagawa O,Ogawa Y,Itoh H,et al.Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy:evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload[J].J Clin Invest,1995,96(3):1280-1287.
  • 3Martin R C.Value of natriuretic peptides in assessment of patients with possibile new heart failure in primary care[J].Lancet,1997,350:1347-1351.
  • 4ferrara R ,Mastrorilli F,Pasanist G,et al.Neurohormonal modulation in chronic heart failure[J].Eur Heart J SuppL,2002,40:403-411.
  • 5Troughton R W,Frampton C M,Yandle T G,et al.Richards A M.Treatment of heart failure guided by plasma aminoterminal brain natriuretie peptide concentrations[J].Lancet,2000,355:1126-1130.
  • 6Maisel A S,Krishnaswamy P,Nowak R N,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med,2002,347(3):161-167.
  • 7Harrison A,Morrison LK,Krishnaswamy P,et al.B-type natriuretie peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J].Ann Emerg Med,2002,39:131-138.
  • 8邵乐文,韩阳,王战坤,孙坚.床边即时脑利钠肽检测对呼吸困难的诊断价值[J].中华心血管病杂志,2004,32(12):1123-1125. 被引量:30
  • 9Berger R,Huelsman M,Strecker K,et a1.B-type natriuretic peptide predicts sudden death in patients with chronic heartfailure[J].Circulation,2002,105:2392-2397.
  • 10Nicholls MG,lainchbury JG,Richards A M,etal.Brain natriuretic peptide-guided therapy for heart failure[J].Ann Med,2001,33;422-427.

二级参考文献18

  • 1[1]Maeda K,Tsutamota T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J,1998,135 : 825-832.
  • 2[2]Maisel AS,Krishnaswamy P, Richards M, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002,347:161-167.
  • 3[3]Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet, 1998,351:9-13.
  • 4[5]Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels . Jpn Heart J, 2000,41: 205-214.
  • 5[6]Cowie MW.BNP: soon to become a routine measure in the care of patients with heart failure? Heart,2000,83:617-618.
  • 6[7]Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med, 2002, 39: 131-138.
  • 7[8]Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriureric peptide in cardiology.J Lab Clin Med, 1999, 134:437-444.
  • 8Collins SP, Ronan-Bentle S, Storrow AB. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea. Ann Emerg Med, 2003, 41: 532-545.
  • 9Shapiro BP, Chen HH, Burnett JC Jr, et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc, 2003, 78:481-486.
  • 10Tjeerdsma G, de Boer RA, Boomsma F, et al. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol,2002, 86:143-149.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部